New data examine stents and bypass surgery in patients with 3VD and LMD
Wednesday, October 15, 2008 - 06:21
in Health & Medicine
Newly reported data presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF) from the SYNTAX clinical trial (SYNergy Between PCI With TAXUS and Cardiac Surgery) reveal similar safety and efficacy outcomes when the use of a drug-eluting stent is compared to heart bypass surgery in patients with left main disease.
Read the whole article on Physorg
More from Physorg
Related
- New data examine stents and bypass surgery in patients with 3VD and LMDWed, 15 Oct 2008, 7:21:26 EDT
- Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trialWed, 15 Oct 2008, 12:22:35 EDT
- Drug-eluting stents better than bare-metal stents for heart attack patientsFri, 25 Sep 2009, 15:35:45 EDT
- Researchers find drug-eluting stents safe, effective for PCI in diabeticsMon, 21 Sep 2009, 14:57:34 EDT
- 12-month ATLANTA trial data show sustained benefit of Catania StentWed, 15 Oct 2008, 7:21:21 EDT